Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy

American Journal of Therapeutics

Volumn 5, Issue 1, 1998, Pages 25-32

  Benatar, Daniel ^b   Hall, Veronica ^b   Reddy, Srinivas ^b   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Heart failure; Nicardipine

Indexed keywords

ALDOSTERONE; CAPTOPRIL; DIGOXIN; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NICARDIPINE; NORADRENALIN; RENIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TREADMILL;

EID: 0031887920     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199801000-00005     Document Type: Article

References (42)

1. Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH: A prospective, randomized, double blind crossover study to compare the efficacy and the safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1961.
2. Multicenter Diltiazem Postinfarction Research Trial Group: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319: 385-392.
3. Elkayam U, Weber L, McKay CR, Rahimtoola SH: Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonist with hydralazine in chronic refractory congestive heart failure. Am J Cardiol 1984;54:126-131.
4. Brooks N, Cattell M, Pidgeon J, Balcon R: Unpredictable response to nifedipine in severe cardiac failure. Br Med J 1980;281:1324.
5. Elkayam U, Weber L, McKay C, Rahimtoola SH: Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol 1985;56:560-566.
6. Packer M, Lee WH, Medina N, Yushak M, Bernstein JL, Kessler PD: Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. J Am Coll Cardiol 1987;10:1303-1311.
7. Barjon JN, Rouleau JL, Bichet D, Juneau C, De Champlain J: Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol 1987;9:622-630.
8. Packer M, Nicod P, Khandheira B, Costello D, Wasserman A, Konstam M, Weiss R, Moyer R, Pinsky D, Abittan M, Souhrada J: Randomized, multicenter, double-blind, placebo-controlled evaluation of amlodipine in patients with mild to moderate heart failure. J Am Coll Cardiol [Abstract] 1991;17(Suppl A):274A.
9. Smith WB, DeAbate AC, Gollub SB, Tonkon M, Grossman W, Sharma S, Goldenberg I, Carley J, Packer M: Beneficial long-term hemodynamic and clinical effects of amlodipine in chronic heart failure: results of a multicenter randomized, double-blind, placebo-controlled, dose-ranging study. Circulation [Abstract] 1994;90(Sup-pl):I-603.
10. Packer M, O'Connor C, Ghali J, Pressler M, Carson P, Belkin R, Miller A, Neuberg G, Frid D, Wertheimer J, Cropp A, DeMets D: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-1114.
11. Aroney CN, Semigran MJ, Dec GW, Boucher CA, Fifer MA: Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol 1989;14:1331-1338.
12. Rousseau MF, Vincent MF, Cheron P, van der Berghe G, Charlier AA, Pouleur H: Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. Br J Clin Pharmacol 1985;20:147S-157S.
13. Ryman KS, Kubo SH, Lystash J, et al: Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. Am J Cardiol 1986;58:583-588.
14. Lahiri A, Robinson CW, Kohli RS, Caruana MP, Raftery EB: Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study. Clin Cardiol 1986;9:257-261.
15. Cody RJ: Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine. Am J Cardiol 1987;59:20J-24J.
16. Lambert CR, Hill JA, Feldman RL, Pepine CJ: Effects of nicardipine on left ventricular function and energetics in man. Int J Cardiol 1986;10:237.
17. Mazzola C, Vaccarella A, Guffanti E, Colnago R, Scarpazza P, Turri DR, Fiorella G: Effects of nicardipine and nifedipine in chronic heart failure: a non invasive study. Cardiologia 1987;32:637-642.
18. Burlew B, Gheorghiade M, Jafri S, Goldberg AD, Goldstein S: Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure. Am Heart J 1987;114:793-804.
19. Sy J, Vitarelli A, Gheorghiade M: Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects. Minerva Cardioangiol 1993;41:535-541.
20. Greenbaum RA, Wan S, Evans TR: The acute haemodyamic effects of nicardipine in patients with chronic left ventricular failure. Eur J Clin Pharmacol 1986;30:383-386.
21. Gheorghiade M, Ferguson D: Digoxin: a neurohormonal modulator in heart failure? Circulation 1991;84:2181-2186.
22. Swedberg K, Eneroth P, Kjekshus J, Wilhemsen L, from the CONSENSUS Trial Study Group: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-1736.
23. Prida XE, Kubo SH, Laragh JH, Cody RJ: Evaluation of calcium-mediated vasoconstriction in chronic conges-tive heart failure. Am J Med 1983;75:795-800.
24. Klugman S, Salvi A, Camerini F: Hemodynamic effects of nifedipine in heart failure. Br Heart J 1980;43:440-446.
25. Matsumoto S, Ito T, Sada T, Takahashi M, Su KM, Ueda A, Okabe F, Sato M, Sekine I, Ito I: Hemodynamic effects of nifedipine in congestive heart failure. Am J Cardiol 1980;46:476-480.
26. Hanrath P, Kremer P, Bleifeld W: Influence of nifedipine on left ventricular dysfunction at rest and during exercise. Eur Heart J 1982;3:325-330.
27. Elkayam U, Roth A, Hsueh W, Weber L, Freidenberger L, Rahimtoola SH: Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in se-vere congestive heart failure. Am Heart J 1986;111:1130-1138.
28. Fifer MA, Colucci WS, Lorell BH, Jaski BE, Barry WH: Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. J Am Coll Cardiol 1985;5:731-737.
29. Ferlin J, Gallo CT: Responses of patients in heart failure to long term oral verapamil administration. Circulation [Abstract] 1984;70(Supp II):II-305.
30. The Danish Study Group on Verapamil in Myocardial Infarction: Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990;66:779-785.
31. Packer M, Lee WH, Meidna N, Yushak M: Comparative negative inotropic effects of nifedipine and diltiazem in patients with severe left ventricular dysfunction. Circulation [Abstract] 1985;72(Supp III):III-275.
32. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, and the MDPIT Group: Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
33. Figulla HR, Gietzen F, Zeymer U, Raiber M, Hegselmann J, Soballa R, Hilgers R: Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Circulation 1996;94: 346-352.
34. Packer M: Second generation calcium channel blockers in the treatment of chronic heart failure: are they any better than their predecessors? J Am Coll Cardiol 1989; 14:1339-1342.
35. Packer M: Calcium channel blockers in chronic heart failure. The risk of "physiologically rational" therapy. Circulation 1990;82:2254-2257.
36. de Vries RJ, Quere M, Lok DJ, Sijbring P, Bucx JJ, van Veldhuisen DJ, Dunselman PH: Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure. Am J Cardiol 1995;76:1253-1258.
37. Boden WE, Ziesche S, Carson PE, Conrad CH, Syat D, Cohn JN: Rationale and design of the Third VasodilatorHeart Failure Trial (VHeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. Am J Cardiol 1996;77:1078-1082.
38. Cohn J, Ziesche S, Loss L, Anderson G, and the V-HeFT Study Group: Effect of felodipine on short-term exercise and neurohormone and long-term mortality in heart failure: results of V-HeFT III Circulation [Abstract] 1995;92:I-143.
39. Goldsmith SR: Effect of amlodipine and felodipine on sympathetic activity and baroreflex function in normal humans. Am J Hypertens 1995;8:902-908.
40. Packer M: Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure. Eur Heart J 1995;16:F4-F6.
41. Bellet M, Sassano P, Guyenne T, Corvol P, Menard J: Converting-enzyme inhibition buffers: the counterregulatory response to acute administration of nicardipine. Br J Clin Pharmacol 1987;24:465-472.
42. Packer M, Medina N, Yushak M, Meller J: Hemodynamic patterns of response during long term captopril therapy for severe chronic heart failure. Circulation 1983;68:803-812.